Asset Allocation

As of October 31, 2025.
Type % Net
Cash 14.75%
Stock 23.04%
Bond 62.92%
Convertible 0.00%
Preferred 0.02%
Other -0.74%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.97%    % Emerging Markets: 0.00%    % Unidentified Markets: 1.03%

Americas 93.80%
93.46%
Canada 53.63%
United States 39.82%
0.35%
As of October 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.43%
United Kingdom 0.90%
3.53%
France 0.44%
Ireland 0.64%
Italy 0.87%
Netherlands 0.85%
Spain 0.72%
Switzerland -0.01%
0.00%
0.00%
Greater Asia 0.73%
Japan 0.30%
0.16%
Australia 0.16%
0.28%
Singapore -0.00%
Taiwan 0.28%
0.00%
Unidentified Region 1.03%

Bond Credit Quality Exposure

AAA -116.8%
AA -32.04%
A 58.54%
BBB 123.0%
BB 34.91%
B 6.35%
Below B 3.83%
    CCC 3.83%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.38%
Not Available 20.79%
Short Term 0.00%
As of October 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
25.97%
Materials
0.39%
Consumer Discretionary
3.68%
Financials
5.89%
Real Estate
16.02%
Sensitive
22.48%
Communication Services
3.72%
Energy
4.36%
Industrials
5.41%
Information Technology
8.99%
Defensive
12.04%
Consumer Staples
-0.58%
Health Care
3.94%
Utilities
8.68%
Not Classified
39.51%
Non Classified Equity
-0.00%
Not Classified - Non Equity
39.51%
As of October 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of October 31, 2025
Type % Net
Government -159.5%
Corporate 243.3%
Securitized 2.30%
Municipal 0.00%
Other 13.87%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
-0.09%
Less than 1 Year
-0.09%
Intermediate
77.91%
1 to 3 Years
4.19%
3 to 5 Years
61.16%
5 to 10 Years
12.57%
Long Term
21.36%
10 to 20 Years
9.76%
20 to 30 Years
1.38%
Over 30 Years
10.22%
Other
0.81%
As of October 31, 2025
View Bond Maturity Exposure
Start Trial